undefined
The trademark application Rynfloza was filed by Novo Nordisk Health Care AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on October 16, 2025, and still open for oppositions.
The application was filed in Danish (English was selected as the second language).